Results 221 to 230 of about 25,819,872 (363)

PEP-Hep: A cluster randomised controlled trial of a prison education programme to improve hepatitis B and C testing uptake and treatment initiation in Ghana - A study protocol. [PDF]

BMJ Open
Senoo-Dogbey VE, Dzansi G, Akpagloh MC, Wuaku DA, Owusu Darkwa I, Boadu AA, Michael DA, Dzantor EK, Anatsui PJ.   +8 more
europepmc   +1 more source

Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies [PDF]

Andrea Maurizio Cabibbe, Kiarash Moghaddasi, Virginia Batignani, Godstime Stephen Kojo Morgan, Federico Di Marco, Daniela María Cirillo   +5 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Testing, Testing [PDF]

Journal of Chemical Education, 2001
openaire   +1 more source

TESTING SIGNIFICANCE OF INCONGRUENCE

, 1994
J. Farris, M. Källersjö, A. Kluge, C. Bult   +3 more
semanticscholar   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Cost and impact of decentralized tuberculosis testing: a modeling analysis of price thresholds for molecular instruments in high-burden settings. [PDF]

EClinicalMedicine
Ockhuisen T, de Nooy A, Girdwood S, Hansen MA, Kohli M, Ruhwald M, Ismail N, Nichols BE.   +7 more
europepmc   +1 more source

N_LyST: a simple and rapid screening test for Lynch syndrome

, 2018
Susanti Susanti, Wakkas Fadhil, Henry O Ebili, Abutaleb Asiri, Aušrinė Nestarenkaitė, Efthymios Hadjimichael, Hersh Abdul Ham-Karim, Joanne Field, Katherine A. Stafford, Balwir Matharoo‐Ball, James Hassall, Abid Sharif, Anca Oniscu, Mohammad Ilyas   +13 more
openalex   +2 more sources

Evidencing inhibitory deficits in Alzheimer?s disease through interference effects and shifting disabilities in the Stroop test [PDF]

, 2003
Hélène Amieva
openalex   +1 more source